Craft
  • Home
  •  / Sartorius Stedim Biotech
Sartorius Stedim Biotech

Sartorius Stedim Biotech

Order Intake

€885.5 M

Q2, 2021

Revenue

€2.9 B

FY, 2021

Market Capitalization

€29.7 B

2022-09-20

Sartorius Stedim Biotech Summary

Company summary

Overview
Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry. Its integrated solutions include fermentation, filtration, purification, fluid management, cell culture media, and lab technologies that support the biopharmaceutical industry to develop and produce drugs.
Type
Public
Founded
2007
HQ
Aubagne, FR | view all locations
Sectors

Key people

  • Joachim Kreuzburg

    Joachim Kreuzburg, CEO and Chairman

    • René Fáber

      René Fáber, Member of the Board

    • Chrystel Baudere

      Chrystel Baudere, Member of the Board

    • Anne-Marie Graffin

      Anne-Marie Graffin, Member of the Board

    Operating MetricsView all

    Order Intake

    €885.5M
    72.3%

    Q2, 2021

    LocationsView all

    3 locations detected

    • Aubagne, Provence-Alpes-Côte d'Azur HQ

      France

      Avenue de Jouques, ZI des Paluds

    • Bohemia, NY

      United States

      5 Orville Drive

    • Jaipur, RJ

      India

      # 69/2 & 69/3, NH48, Jakkasandra

    Sartorius Stedim Biotech Financials

    Summary financials

    Revenue (Q2, 2022)
    €861.8M
    Gross profit (Q2, 2022)
    €446.0M
    Net income (Q2, 2022)
    €214.8M
    Cash (Q2, 2022)
    €156.1M
    EBIT (Q2, 2022)
    €257.4M
    Enterprise value
    $30.3B

    Footer menu